18F-DOPA uptake does not correlate with IDH mutation status and 1p/19q co-deletion in glioma
暂无分享,去创建一个
Francesco Scopinaro | Claudia Scaringi | Felice Giangaspero | F. Giangaspero | A. Arcella | G. Minniti | F. Scopinaro | C. Scaringi | Francesco Cicone | Giuseppe Minniti | F. Cicone | Luciano Carideo | Antonietta Arcella | Luciano Carideo
[1] F. Giangaspero,et al. Chemoradiation for anaplastic oligodendrogliomas: clinical outcomes and prognostic value of molecular markers , 2013, Journal of Neuro-Oncology.
[2] Y. Iwadate,et al. Discrimination between low-grade oligodendrogliomas and diffuse astrocytoma with the aid of 11C-methionine positron emission tomography. , 2011, Journal of neurosurgery.
[3] Val J Lowe,et al. Biopsy validation of 18F-DOPA PET and biodistribution in gliomas for neurosurgical planning and radiotherapy target delineation: results of a prospective pilot study. , 2013, Neuro-oncology.
[4] Ian Law,et al. Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas. , 2016, Neuro-oncology.
[5] Kenji Hirata,et al. Oligodendroglial component complicates the prediction of tumour grading with metabolic imaging , 2015, European Journal of Nuclear Medicine and Molecular Imaging.
[6] Marie Blonski,et al. A high 18F-FDOPA uptake is associated with a slow growth rate in diffuse Grade II-III gliomas. , 2017, The British journal of radiology.
[7] Yasuo Iwadate,et al. Molecular imaging of 1p/19q deletion in oligodendroglial tumours with 11C-methionine positron emission tomography , 2016, Journal of Neurology, Neurosurgery & Psychiatry.
[8] T. Huber,et al. Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma. , 2016, World neurosurgery.
[9] N. Galldiks,et al. The role of amino-acid PET in the light of the new WHO classification 2016 for brain tumors. , 2018, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....
[10] 篠﨑 夏樹. Discrimination between low-grade oligodendrogliomas and diffuse astrocytoma with the aid of 11C-methionine positron emission tomography , 2012 .
[11] Nadim Jon Shah,et al. Amino acid PET and MR perfusion imaging in brain tumours , 2017, Clinical and Translational Imaging.
[12] Paul Cumming,et al. Prediction of oligodendroglial histology and LOH 1p/19q using dynamic [(18)F]FET-PET imaging in intracranial WHO grade II and III gliomas. , 2012, Neuro-oncology.
[13] Nadim Jon Shah,et al. Advances in neuro-oncology imaging , 2017, Nature Reviews Neurology.
[14] Alexander R. Pico,et al. Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors. , 2015, The New England journal of medicine.
[15] Gereon R Fink,et al. Static and dynamic 18F–FET PET for the characterization of gliomas defined by IDH and 1p/19q status , 2018, European Journal of Nuclear Medicine and Molecular Imaging.
[16] E Guedj,et al. IDH mutation is paradoxically associated with higher 18F-FDOPA PET uptake in diffuse grade II and grade III gliomas , 2017, European Journal of Nuclear Medicine and Molecular Imaging.
[17] A. Bizzi,et al. Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma , 2017, European Journal of Nuclear Medicine and Molecular Imaging.
[18] B. Scheithauer,et al. The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.
[19] M. Mamede,et al. 18F-DOPA uptake parameters in glioma: effects of patients' characteristics and prior treatment history. , 2018, The British journal of radiology.
[20] Leland S. Hu,et al. Biopsy validation of 18 F-DOPA PET and biodistribution in gliomas for neurosurgical planning and radiotherapy target delineation : results of a prospective pilot study , 2013 .
[21] G. Reifenberger,et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.
[22] Karl-Josef Langen,et al. Voxel-based 18F-FET PET segmentation and automatic clustering of tumor voxels: A significant association with IDH1 mutation status and survival in patients with gliomas , 2018, PloS one.